Johnson & Johnson (JNJ) Cash Flow Statement

Click line-items for a historical chart and %

Net earnings
Depreciation and amortization of property and intangibles	2.7B
Stock based compensation	704M
Deferred tax provision	215M
Accounts receivable allowances	-10M
Increase in accounts receivable	-736M
Increase in inventories	-408M
Decrease in accounts payable and accrued liabilities	-1.22B
Increase in other current and non-current assets	-379M
Increase in other current and non-current liabilities	-1.39B
NET CASH FLOWS FROM OPERATING ACTIVITIES	12.11B
Additions to property, plant and equipment	-2.13B
Proceeds from the disposal of assets	873M
Acquisitions, net of cash acquired	-4.05B
Purchases of investments	-27.68B
Sales of investments	30.44B
Other	-37M
NET CASH USED BY INVESTING ACTIVITIES	-2.59B
Dividends to shareholders	-6.45B
Repurchase of common stock	-6.95B
Proceeds from short-term debt	149M
Retirement of short-term debt	-3.93B
Proceeds from long-term debt	11.95B
Retirement of long-term debt	-953M
Proceeds from the exercise of stock options/ excess tax benefits
NET CASH USED BY FINANCING ACTIVITIES	-5.09B
Effect of exchange rate changes on cash and cash equivalents	33M
Decrease in cash and cash equivalents	4.47B
Cash and Cash equivalents, beginning of period	13.73B
CASH AND CASH EQUIVALENTS, END OF PERIOD	18.21B
Fair value of assets acquired	4.09B
Fair value of liabilities assumed and non-controlling interests	-44M
Net cash paid for acquisitions	4.05B

Entities mentioned with JNJ

View All Entities